NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has granted instruments and given funding to the University of Michigan for its prostate cancer research programs.

Under the grant, Agilent is contributing a 1200 Series liquid chromatography system, and a 1200 Series Rapid Resolution LC system coupled to a 6530 Accurate Mass quadrupole time-of-flight mass spectrometer to the school's Center for Translational Pathology. The company did not disclose how much funding it granted to the school under the agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.